http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01125384-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
filingDate 1987-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c4256b46864efb65cc2d247a76770e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_014189ea0d559121d00004c8aedf4e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b2665aa2bc63ee0b1a873dd190b328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0379fdca1649d8aad34f973dd789d4a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee71bcc861257ccc553cb7bc9ba03b33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0db08781a69b8ef5d46d7f094ffe0fde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b45dfeb7adc58cff483d4029c87202
publicationDate 1989-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01125384-A
titleOfInvention Novel cephalosporin compound and antimicrobial agent
abstract NEW MATERIAL:A compound expressed by formula I (R 1 and R 2 represent H or 1W5C alkyl; R 3 represents 1W5C alkyl optionally containing halogen, alkenyl or 3W6C cycloalkylmethyl; A represents H or nucleophilic compound's residue) and salt thereof. n EXAMPLE: (6R,7R)7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(1-methoxy-5-hydroxy-4-pyridon-2- yl)methoxyiminoacetamido]-3-(1,2,3-thiadiazol-5-yl)thiomethyl-ceph-3-em-4- carboxylic acid. n USE: An antimicrobial agent useful for Gram-positive bacteria and Gram-negative bacteria including Pseudomonas aeruginosa, which also has powerful action against β-latamase-producing bacteria. n PREPARATION: A compound expressed by formula II (R 10 represents H or amino- protecting group) or reactive derivative thereof is reacted with a compound expressed by formula III (R 11 represents H or carboxy-protecting group), etc., followed by elimination of protecting groups. n COPYRIGHT: (C)1989,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9202523-A1
priorityDate 1987-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234747635
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15159582
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID287

Total number of triples: 33.